Cardiovascular effects of the addition of nilotinib to standard therapy for acute myeloid leukemia

Carolyn M. Larsen; Hector R. Villarraga; Kebede H. Begna; Mark R. Litzow; Aref Al-Kali; Joerg Herrmann

doi:10.1080/10428194.2017.1323268

Cardiovascular effects of the addition of nilotinib to standard therapy for acute myeloid leukemia

Carolyn M. Larsen, Hector R. Villarraga, Kebede H. Begna, Mark R. Litzow, Aref Al-Kali, Joerg Herrmann

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	229-232
Number of pages	4
Journal	Leukemia and Lymphoma
Volume	59
Issue number	1
DOIs	https://doi.org/10.1080/10428194.2017.1323268
State	Published - Jan 2 2018

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

Access to Document

10.1080/10428194.2017.1323268

Cite this

@article{1377833eb97b45278c3887ddf9413d8f,

title = "Cardiovascular effects of the addition of nilotinib to standard therapy for acute myeloid leukemia",

author = "Larsen, {Carolyn M.} and Villarraga, {Hector R.} and Begna, {Kebede H.} and Litzow, {Mark R.} and Aref Al-Kali and Joerg Herrmann",

year = "2018",

month = jan,

day = "2",

doi = "10.1080/10428194.2017.1323268",

language = "English (US)",

volume = "59",

pages = "229--232",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "1",

}

TY - JOUR

T1 - Cardiovascular effects of the addition of nilotinib to standard therapy for acute myeloid leukemia

AU - Larsen, Carolyn M.

AU - Villarraga, Hector R.

AU - Begna, Kebede H.

AU - Litzow, Mark R.

AU - Al-Kali, Aref

AU - Herrmann, Joerg

PY - 2018/1/2

Y1 - 2018/1/2

UR - http://www.scopus.com/inward/record.url?scp=85020478708&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020478708&partnerID=8YFLogxK

U2 - 10.1080/10428194.2017.1323268

DO - 10.1080/10428194.2017.1323268

M3 - Letter

C2 - 28592197

AN - SCOPUS:85020478708

SN - 1042-8194

VL - 59

SP - 229

EP - 232

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 1

ER -

Cardiovascular effects of the addition of nilotinib to standard therapy for acute myeloid leukemia

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this